Genetic mutation test kit CapitalBio 300069
for PCRfluorescence

genetic mutation test kit
genetic mutation test kit
Add to favorites
Compare this product


for genetic mutations
Analysis mode
for PCR, fluorescence


According to the WHO, 360 million individuals, or more than 5% of the world’s population, suffers disabling hearing loss. Hearing loss produces significant negative impacts on individuals’ lives as well as on society. Aminoglycoside-Induced Deafness Gene Mutations Detection Kit is designed for a rapid and accurate detection of gene mutations related to deafness caused by the use of aminoglycosides. It employs fluorescence quantitative PCR technology and covers two mutations in one gene. It helps to identify individuals likely to suffer hearing loss after using aminoglycosides and allows precautions to be taken to avoid deafness caused by inappropriate use of aminoglycosides.
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.